Inhibition of Myeloperoxidase Pro-Fibrotic Effect by Noscapine in Equine Endometrium

• Autor(a) principal: Amaral, Ana
• Data de Publicação: 2023
• Outros Autores: Cebola, Nélio, Szóstek-Mioduchowska, Anna, Rebordão, Maria Rosa, Kordowitzki, Paweł, Skarzynski, Dariusz, Ferreira-Dias, Graça
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10174/34611; https://doi.org/Amaral, A.; Cebola, N.; Szóstek-Mioduchowska, A.; Rebordão, M.R.; Kordowitzki, P.; Skarzynski, D.; Ferreira-Dias, G. Inhibition of Myeloperoxidase Pro-Fibrotic Effect by Noscapine in Equine Endometrium. Int. J. Mol. Sci. 2023, 24, 3593. https://doi.org/ 10.3390/ijms24043593; https://doi.org/10.3390/ijms24043593
• topic: equine; endometrosis; fibrosis; myeloperoxidase; noscapine; inhibition; collagen

Myeloperoxidase is an enzyme released by neutrophils when neutrophil extracellular traps (NETs) are formed. Besides myeloperoxidase activity against pathogens, it was also linked to many diseases, including inflammatory and fibrotic ones. Endometrosis is a fibrotic disease of the mare endometrium, with a large impact on their fertility, where myeloperoxidase was shown to induce fibrosis. Noscapine is an alkaloid with a low toxicity, that has been studied as an anti-cancer drug, and more recently as an anti-fibrotic molecule. This work aims to evaluate noscapine inhibition of collagen type 1 (COL1) induced by myeloperoxidase in equine endometrial explants from follicular and mid-luteal phases, at 24 and 48 h of treatment. The transcription of collagen type 1 alpha 2 chain (COL1A2), and COL1 protein relative abundance were evaluated by qPCR and Western blot, respectively. The treatment with myeloperoxidase increased COL1A2 mRNA transcription and COL1 protein, whereas noscapine was able to reduce this effect with respect to COL1A2 mRNA transcription, in a time/estrous cycle phase-dependent manner (in explants from the follicular phase, at 24 h of treatment). Our study indicates that noscapine is a promising drug to be considered as an anti-fibrotic molecule to prevent endometrosis development, making noscapine a strong candidate to be applied in future endometrosis therapies.